AdvaMed Escalates Opposition To Inpatient Proposal With Ad Campaign
This article was originally published in The Gray Sheet
AdvaMed is targeting members of Congress with an ad campaign to pressure CMS to revise its approach to overhauling the hospital inpatient payment system
You may also be interested in...
Steve Ubl has led AdvaMed for 10 years, raising profile of device industry on Capitol Hill and executing well-regarded public relations campaign of the kind the drug industry might need as it enters political maelstrom on pricing.
Steve Ubl has led AdvaMed for 10 years, raising profile of device industry on Capitol Hill, but also developing reputation of his own as a policy wonk.
AdvaMed CEO Steve Ubl is leaving the device trade association to take the helm of the Pharmaceutical Research and Manufacturers of America. Ubl has led AdvaMed for 10 years, raising the profile of the device industry among policymakers, fighting perception battles and, of course, opposing the device tax.